Navigation Links
Synergy Life Science Partners Closes $143M Debut Medical Device Fund
Date:1/9/2008

PORTOLA VALLEY, Calif., Jan. 9 /PRNewswire/ -- Synergy Life Science Partners, LP, a venture capital limited partnership focused on investments in emerging medical device technologies, today announced the successful completion of fundraising for its debut fund with an aggregate of $143 million in committed capital. The firm has closed on six investments to date.

Founded in 2006 by John Onopchenko, Richard Stack, M.D., and William Starling, Synergy invests directly in private, early-stage medical device firms or emerging companies that are developing disruptive technologies to address unmet or under-served human healthcare needs. Areas of therapeutic interest include cardiovascular disease, orthopedic and spinal diseases and injuries, metabolic disorders such as diabetes and obesity, neuro-mediated disorders, oncology and ophthalmic conditions.

"We're excited about our fundraising accomplishments and our early portfolio," said Onopchenko, a managing director of Synergy. "We've received a great deal of support from our new limited partners, who share our vision for building and accelerating the delivery of innovative medical products. Our goal is to help dramatically improve the standard of patient care in our therapeutic categories, while generating exceptional returns to the customers of and investors in our portfolio companies."

For Synergy's limited partners, the decision to participate has been based on a unique set of factors. "Synergy's innovative strategy for medical device investing is an ideal fit for our portfolio," said Tracy Harris, Director for Parish Capital Advisors, LLP. "We believe the unmatched industry expertise of the managing directors and the fund's strategy of targeting early-stage companies in large therapeutic areas position Synergy to offer outsized returns for investors."

Synergy intends to invest in early-stage companies in large therapeutic areas in both the medical device and the combination product sect
'/>"/>

SOURCE Synergy Life Science Partners, LP
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. Health Integrated to Showcase Synergy Personal Health Management(R) at DMAA Conference
2. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
3. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
4. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
7. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
8. John B. Buse, MD, PhD of Chapel Hill, NC, Elected American Diabetes Association President, Medicine & Science
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. SAMHSA Announces First Science and Service Award Winners
11. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...g to a new study by researchers in National Instit...g clinical signs of dementia increases with the nu...e brain. Among their findings is the observation ...ase and cerebral infarcts (strokes) is the most co...
...h International Congress on Hair Research will be ...e largest gathering of hair experts, with clinicia...disease and treatment. Whether long or short, thi... a person emotionally. Hair loss is not simply a m...
World Blood Donor Day
...known generically as anidulafungin was shown to be...nvasive candidiasis, a potentially fatal blood inf...een hobbled. This is according to a research by Dr...n Camden, New Jersey, and colleagues who published...
Other Medicine News:Health News:Mix of Disease Process in Brain Leads to Dementia 2Health News:World Largest Hair Congress Convene in Vancouver 2Health News:World Blood Donor Day 2Health News:New Anti Fungal Drug Eraxis as Good as the Older Medicine 2
(Date:10/14/2008)...t. 14 /- Paratek Pharmaceuticals, Inc...acycline, formerly PTK 0796, a,first-in-class amin...ker,poster presentation at the 48th Interscience C... (ICAAC). ICAAC will be held in Washington, D.C.,f...ion on the poster session at ICAAC:, Sunday, O...
(Date:10/14/2008)...Data Presentation Shows Encouraging 12-Month Outco...with Predominantly Complex Lesions, WASHINGTON, O...that an,interim analysis of 12-month follow-up dat...ety and efficacy in the real-world use of the,comp...y Professor Robbert de Winter, M.D., Ph.D., of the...
(Date:10/13/2008)...ew 1.5 million dollar NIH funding advances study ...rvival rates, MINNEAPOLIS, Oct. 13 /...advancedcirculatory.com ) announced today that it ... from the National Institutes of,Health (NIH) to c...ation on,those who experience cardiac arrest outsi...
(Date:10/13/2008)...E, Md., Oct. 13 /- Neuronascent, Inc....hat the Company has received,funding from multiple...neurogenic compounds targeting Alzheimer,s disease...ed grants and funding from Maryland,Department of ...ment,Program; Maryland Industrial Partnerships in ...
Breaking Medicine Technology:Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 2Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 3Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs 2ABC Releases Monograph on Scientific Research of POM Wonderful 28R 29 Pomegranate Juice 25331 1ABC Releases Monograph on Scientific Research of POM Wonderful 28R 29 Pomegranate Juice 25331 2ABC Releases Monograph on Scientific Research of POM Wonderful 28R 29 Pomegranate Juice 25331 3ABC Releases Monograph on Scientific Research of POM Wonderful 28R 29 Pomegranate Juice 25331 4Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less than 7094 1Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less than 7094 2Angiotech receives CE Mark approval of HemoStream 28TM 29 Chronic Dialysis Catheter 7092 1Angiotech receives CE Mark approval of HemoStream 28TM 29 Chronic Dialysis Catheter 7092 2Angiotech receives CE Mark approval of HemoStream 28TM 29 Chronic Dialysis Catheter 7092 3Angiotech receives CE Mark approval of HemoStream 28TM 29 Chronic Dialysis Catheter 7092 4Stunning Attendance for ChemOutsourcing Show on September 8 9 in Long Branch NJ 7090 1Stunning Attendance for ChemOutsourcing Show on September 8 9 in Long Branch NJ 7090 2
... 12, 2007 - Results from the,successful clinical t...CTIVE(R) (gemifloxacin mesylate) tablets for the f...of mild to moderate,severity (CAP) have been publi...l of Antimicrobial Chemotherapy, currently,availab... clinical,trial comparing a five-day and seven-day...
...RNewswire/ -- Accera, Inc.,today is presenting dat...inical trial of AC-1202 (Ketasyn) in Alzheimer,s d...national Conference on,Prevention of Dementia in W...rlier clinical and preclinical studies, AC-1202 wa...e memory and,cognition of subjects of a particular...
Other Medicine Technology:July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 2July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 3July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 4July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 5Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4
Integrate RFID and bar code technology with the new DR1000 Dual RFID/Bar Code Reader by Precision Dynamics Corporation (PDC). It provides an easy migration from bar codes to RFID tags for healthcare
VerdaSees Navigaton™ software facilitates real time information collection. It is composed of two modules: the first module is a software link between various RFID reader devices and the databa
The AeroScout Engine is a core software component of the AeroScout Visibility System, which enables location-based applications in a wireless LAN environment. Core capabilities of the AeroScout Engin
...a wandering resident from leaving a facility undet... typically have been diagnosed with dementia, Alzh...-risk residents wear a small Watchlet™ brace...e discreetly secured by WatchMate monitors. When a...
Medicine Products: